Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol... see more

NDAQ:TLRY - Post Discussion

Tilray Brands Inc > The US will Legalize Cannabis
View:
Post by quinlash on Jun 21, 2024 11:13am

The US will Legalize Cannabis

When Canada Legalized cannabis back in 2018 it was largely expected that the US would follow shortly afterwards and the stocks were trending around their record highs.  This did not happen and many lost interest in the stocks and exited.

When Biden was elected in 2020 he has campaigned on a promise to progress Cannabis and again the stocks ramped up to their highs of the period. Again, notable progress was not seen and investors exited positions 

In 2024 the DEA and HHS have been directed by the US Fed to progress Cannabis legalization ASAP which, at the speed of government policy change, is slower and longer than the attention span of the average investor. 

Currently we are waiting on feedback from the DEA in regards to rescheduling cannabis to a schedule 3 drug which will move it to a less regulated substance.  

Speculation now is that progress will actually be seen due to it being an election year and the Biden administration will use cannabis legalization as a means to win votes.

Tilray already has sales of product into the US in the form of medical cannabis and it's line of craft beers.  Tilray has also announced it's plans to acquire another company that will further enable it's launch into the US.

Tilray will be reporting its 2024 year end report in July where it can be expected to show net sales in the high 700 to low 800 million USD dollars / apx 1 Billion Canadian.  Fintel estimates the Q4 numbers alone will be apx 225 million USD. 

The report will likely not be a EPS positive report however it will be a further confirmation that the company is growing well and on track to be one of a very few cannabis companies to successfully run the gauntlet of the markets and come out on top.
Comment by quinlash on Jun 21, 2024 11:44am
Revenue numbers noted are Net, not Gross. Had I used Gross they would be substantially higher.  Expenses this year may be lower as last year TLRY had some one time expenses tied to their various acquisitions. You can work out the numbers (roughly) by going through all the various reports by the company or going though as many forecast estimates you can find from various 3rd party sites to ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities